IBB Among Technology ETFs
End-of-day Nov 16, 2026 · 54 Technology ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −5.3% | +3.0% | +2.2% | +23.3% | +27.6% | +82.2% | +33.6% | +699.9% |
| Peer average | −2.9% | −3.9% | −7.3% | −10.9% | +3.1% | +4.6% | +69.6% | +21.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$90 of every $1,000 in IBB is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 8.96% | $896.07 | 5.9M | $988.5M |
| 2 | AMGNAmgen | Healthcare | 8.48% | $848.30 | 2.0M | $935.8M |
| 3 | VRTXVertex Pharmaceuticals | Healthcare | 7.78% | $778.05 | 1.6M | $858.3M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 6.51% | $651.33 | 755K | $718.5M |
| 5 | MRNAModerna | Healthcare | 5.84% | $583.90 | 2.8M | $644.1M |
| 6 | ARGXArgenx SE | Healthcare | 3.77% | $376.71 | 423K | $415.6M |
| 7 | NTRANatera | Healthcare | 3.00% | $300.40 | 1.0M | $331.4M |
| 8 | BIIBBiogen | Healthcare | 2.54% | $253.79 | 1.1M | $280.0M |
| 9 | ONCBeone Medicines AG | Healthcare | 2.42% | $241.73 | 641K | $266.7M |
| 10 | RVMDRevolution Medicines | Healthcare | 2.35% | $234.88 | 1.5M | $259.1M |
| 11 | ILMNIllumina | Healthcare | 2.18% | $218.04 | 1.1M | $240.5M |
| 12 | GMABGenmab Sponsored | Healthcare | 1.98% | $198.00 | 4.2M | $218.4M |
| 13 | INSMInsmed | Healthcare | 1.75% | $175.48 | 1.6M | $193.6M |
| 14 | UTHRUnited Therapeutics | Healthcare | 1.70% | $169.94 | 316K | $187.5M |
| 15 | INCYIncyte | Healthcare | 1.69% | $168.89 | 1.5M | $186.3M |
of the $354B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 8.96% |
| 2 | AMGN | Amgen | 8.48% |
| 3 | VRTX | Vertex Pharmaceuticals | 7.78% |
| 4 | REGN | Regeneron Pharmaceuticals | 6.51% |
| 5 | MRNA | Moderna | 5.84% |
| 6 | ARGX | Argenx SE | 3.77% |
| 7 | NTRA | Natera | 3.00% |
| 8 | BIIB | Biogen | 2.54% |
| 9 | ONC | Beone Medicines AG | 2.42% |
| 10 | RVMD | Revolution Medicines | 2.35% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.0112 |
| Jun 15, 2026 | Jun 18, 2026 | $0.0238 |
| Mar 17, 2026 | Mar 20, 2026 | $0.12 |
| Dec 16, 2025 | Dec 19, 2025 | $0.18 |
| Sep 16, 2025 | Sep 19, 2025 | $0.0828 |
| Mar 18, 2025 | Mar 21, 2025 | $0.12 |
| Dec 17, 2024 | Dec 20, 2024 | $0.0624 |
| Sep 25, 2024 | Sep 30, 2024 | $0.20 |
| Mar 21, 2024 | Mar 27, 2024 | $0.13 |
| Dec 20, 2023 | Dec 27, 2023 | $0.12 |
| Sep 26, 2023 | Oct 2, 2023 | $0.15 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0062 |